Talis Biomedical (TLIS) Competitors $1.50 0.00 (0.00%) As of 09/25/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLIS vs. ASTC, BNGO, SMIT, SPEC, TBIO, THMO, HTGMQ, OLITW, PRENW, and QSIAWShould you be buying Talis Biomedical stock or one of its competitors? The main competitors of Talis Biomedical include Astrotech (ASTC), Bionano Genomics (BNGO), Schmitt Industries (SMIT), Spectaire (SPEC), Telesis Bio (TBIO), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), and Quantum-Si (QSIAW). These companies are all part of the "measuring and control equipment" industry. Talis Biomedical vs. Its Competitors Astrotech Bionano Genomics Schmitt Industries Spectaire Telesis Bio ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si Astrotech (NASDAQ:ASTC) and Talis Biomedical (NASDAQ:TLIS) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk. Which has preferable earnings & valuation, ASTC or TLIS? Astrotech has higher revenue and earnings than Talis Biomedical. Astrotech is trading at a lower price-to-earnings ratio than Talis Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAstrotech$1.05M8.20-$11.67M-$8.39-0.61Talis Biomedical$300K9.12-$62.01M-$28.02-0.05 Does the media refer more to ASTC or TLIS? In the previous week, Astrotech had 4 more articles in the media than Talis Biomedical. MarketBeat recorded 4 mentions for Astrotech and 0 mentions for Talis Biomedical. Astrotech's average media sentiment score of 0.32 beat Talis Biomedical's score of 0.00 indicating that Astrotech is being referred to more favorably in the media. Company Overall Sentiment Astrotech Neutral Talis Biomedical Neutral Which has more volatility and risk, ASTC or TLIS? Astrotech has a beta of 0.34, suggesting that its share price is 66% less volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.31, suggesting that its share price is 31% more volatile than the S&P 500. Do institutionals & insiders have more ownership in ASTC or TLIS? 24.4% of Astrotech shares are held by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are held by institutional investors. 14.9% of Astrotech shares are held by company insiders. Comparatively, 46.0% of Talis Biomedical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is ASTC or TLIS more profitable? Talis Biomedical has a net margin of 0.00% compared to Astrotech's net margin of -1,320.31%. Astrotech's return on equity of -48.94% beat Talis Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Astrotech-1,320.31% -48.94% -44.71% Talis Biomedical N/A -79.74%-57.16% SummaryAstrotech beats Talis Biomedical on 7 of the 13 factors compared between the two stocks. Get Talis Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for TLIS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLIS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLIS vs. The Competition Export to ExcelMetricTalis BiomedicalAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.73M$1.38M$5.63B$10.31BDividend YieldN/AN/A5.77%4.65%P/E Ratio-0.05N/A75.7526.15Price / Sales9.123.04479.95100.63Price / CashN/AN/A37.1160.83Price / Book0.040.0612.416.36Net Income-$62.01M-$43.77M$3.29B$270.97M7 Day PerformanceN/AN/A1.23%0.33%1 Month PerformanceN/AN/A3.39%6.05%1 Year Performance-25.00%-25.00%63.27%27.33% Talis Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLISTalis BiomedicalN/A$1.50flatN/A-26.5%$2.73M$300K-0.05260ASTCAstrotech0.4733 of 5 stars$5.48+9.6%N/A-37.3%$8.47M$1.66M0.0010News CoverageEarnings ReportGap UpBNGOBionano Genomics2.1756 of 5 stars$1.68-4.5%$7.50+346.4%-93.7%$8.37M$30.78M0.00300Positive NewsSMITSchmitt IndustriesN/A$0.02flatN/A+30.4%$82K$9.89M0.00160News CoverageSPECSpectaireN/A$0.00flatN/AN/A$7KN/A0.008Gap UpTBIOTelesis BioN/A$0.00flatN/A-99.7%$2K$225.09M0.00200THMOThermoGenesisN/A$0.00+∞N/AN/A$1K$9.61M0.0040Gap UpHTGMQHTG Molecular DiagnosticsN/AN/AN/A-50.0%$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.09-13.7%N/A+168.4%$0.00N/A0.003Gap UpPRENWPrenetics GlobalN/A$0.02-7.2%N/A+130.0%$0.00$57.05M0.001Positive NewsGap DownHigh Trading VolumeQSIAWQuantum-SiN/A$0.31+12.3%N/A+229.5%$0.00$3.41M0.00150High Trading Volume Related Companies and Tools Related Companies ASTC Alternatives BNGO Alternatives SMIT Alternatives SPEC Alternatives TBIO Alternatives THMO Alternatives HTGMQ Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLIS) was last updated on 9/27/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talis Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talis Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLIS Stock Alerts